Gene expression profiling in PC12 cells infected with an oncolytic Newcastle disease virus strain
/in International Publications, Newcastle Disease Virus /von 2014-03-15 / Virus Res. 2014 Jun;185:10-22Viruses for tumor therapy
/in International Publications, Newcastle Disease Virus /von 2014-03-12 / Cell Host Microbe 2014 Mar;15(3):260-5Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy
/in International Publications, Newcastle Disease Virus /von 2014-03-07 / Immunol. Lett. 2014 May-Jun;159(1-2):36-46Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2014-03-05 / Sci Transl Med 2014 Mar;6(226):226ra32Natural killer cells: the secret weapon in dendritic cell vaccination strategies
/in Dendritic Cells, International Publications /von 2014-03-01 / Clin. Cancer Res. 2014 Mar;20(5):1095-103Novel approaches and mechanisms of immunotherapy for glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-03-01 / Discov Med 2014 Mar;17(93):145-54Phase I dendritic cell p53 peptide vaccine for head and neck cancer
/in Dendritic Cells, International Publications /von 2014-02-28 / Clin. Cancer Res. 2014 May;20(9):2433-44Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-02-27 / Oncoimmunology 2014 Jan;3(1):e27589DNA fragmentation and caspase-independent programmed cell death by modulated electrohyperthermia
/in Hyperthermia, International Publications /von 2014-02-22 / Strahlenther Onkol 2014 Sep;190(9):815-22IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de